Inmunología, Oftalmología y ORL
Departamento
![Foto de Inmunología, Oftalmología y ORL](/img/uploaded/7383705E4165CCC3E1D5745D79764C47.png)
![Foto de Instituto de Investigación Sanitaria Fundación Jiménez Díaz](/img/noimage_org.png)
Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Fundación Jiménez Díaz (9)
2024
-
Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase
Communications Biology, Vol. 7, Núm. 1
-
MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension
Science advances, Vol. 10, Núm. 3, pp. eadk6524
-
Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study
Experimental Dermatology, Vol. 33, Núm. 8
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Androgen receptor polyQ alleles and COVID-19 severity in men: A replication study
Andrology, Vol. 11, Núm. 1, pp. 24-31
-
Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations
Journal of Clinical Medicine, Vol. 12, Núm. 19
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR
Nature Biotechnology, Vol. 40, Núm. 11, pp. 1680-1689